Jason Jiang

Jiang Nanchun (; born 1973), also known as Jason Jiang, is a Chinese businessman. He is the founder and CEO of Focus Media, "a multi-platform digital media company that operates out-of-home advertising network using audiovisual digital displays". In 2005 his company went public on the Nasdaq Stock Exchange, and achieved a market capitalization of US$3.6 billion as of 2011. He delisted the company from Nasdaq in 2013, and used a reverse takeover to list the company in China in 2016. In 2018, Forbes estimated his net worth at US$5.4 billion. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Jason Jiang', query time: 0.03s Refine Results
  1. 1
    Improving the Accuracy of Length of stay Risk Adjustment Models using Linked Data

    Improving the Accuracy of Length of stay Risk Adjustment Models using Linked Data by Tolulope Sajobi, Mingshan Lu, Jason Jiang, Hude Quan

    Published 2017-04-01
    Get full text
    Article
  2. 2
    Detrimental impact on work productivity in patients with glaucoma: a systematic review

    Detrimental impact on work productivity in patients with glaucoma: a systematic review by Hamza Inayat, Mura Abdul-Nabi, Bernice Leung, Jason Jiang, Sara Robertson, Monali S. Malvankar-Mehta

    Published 2024-12-01
    Get full text
    Article
  3. 3
    The 2.6 Å Structure of a Tulane Virus Variant with Minor Mutations Leading to Receptor Change

    The 2.6 Å Structure of a Tulane Virus Variant with Minor Mutations Leading to Receptor Change by Chen Sun, Pengwei Huang, Xueyong Xu, Frank S. Vago, Kunpeng Li, Thomas Klose, Xi Jason Jiang, Wen Jiang

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver disease

    Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver disease by Seungwon Lee, Abdel Aziz Shaheen, David J. T. Campbell, Christopher Naugler, Jason Jiang, Robin L. Walker, Hude Quan, Joon Lee

    Published 2024-02-01
    Get full text
    Article
  5. 5
    The Use of Long-Acting Injectable Antipsychotic Therapy for Schizophrenia

    The Use of Long-Acting Injectable Antipsychotic Therapy for Schizophrenia by Jason Jiang, Jeff Bakal, Pierre Chue, Mark Snaterse, Liana Urichuk, Serdar Dursun, Christopher McCabe, Finlay McAlister, Deborah James, Lawrence Richer

    Published 2018-09-01
    Get full text
    Article
  6. 6
    Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids

    Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids by Abdulkhaliq Alsaadi, Mara Artibani, Zhiyuan Hu, Nina Wietek, Matteo Morotti, Laura Santana Gonzalez, Moiad Alazzam, Jason Jiang, Beena Abdul, Hooman Soleymani majd, Levi L. Blazer, Jarret Adams, Francesca Silvestri, Sachdev S. Sidhu, Joan S. Brugge, Ahmed Ashour Ahmed

    Published 2023-11-01
    Get full text
    Article

Search Tools: